Leaderboard

En | De
No articles selected!     View Cart  
You are here: Urology-Nephrology » Neoplasia/BPH 01. July 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 9465  Previews Next
   
   Articles 1 - 20 / 189297  
   
Re: Alexander D. Sherry, Van To, Criselle D'souza, et al. Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.024.
Eur Urol
Cigliola A, Necchi A, Capitanio U.
PMID: 42379926 [PubMed - as supplied by publisher]


Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial.
Eur J Cancer
Fizazi K, Smith MR, Hussain M, Saad F, Sternberg CN, David Crawford E, Aragon-Ching JB, Schostak M, Tutrone R, Morgans AK, Sentana-Lledo D, Joensuu H, Mohamed AF, Littleton N, Srinivasan S, Buttkewitz Y, Li R, Kuss I, Tombal B.
PMID: 42378957 [PubMed - as supplied by publisher]


Transurethral ultrasound ablation for prostate cancer: MRI-based pre-treatment planning and post-treatment assessment-what the radiologist needs to know.
Abdom Radiol (NY)
Takahashi S, Miura M, Higashiyama H.
PMID: 42380349 [PubMed - as supplied by publisher]


Beyond the tumor: Recurrence-prone radiomics for prognostication in negative PSMA PET/CT scans of prostate cancer.
Biomed Phys Eng Express
Yousefirizi F, Harsini S, Mohebi M, Alberts I, Yusufaly T, Luo M, Abdollahi H, Yazdani E, Mirabedian S, Sabouri M, Geramifar P, Sheikhzadeh P, Martineau P, Wilson D, Bénard F, Uribe CF, Rahmim A.
PMID: 42379193 [PubMed - as supplied by publisher]


Association of Cumulative Proton Pump Inhibitor Use with Prostate Cancer Risk and Outcomes: A Population-Based Cohort Study.
Cancer Res Commun
Sayyid RK, Tiwari R, Zhang B, Wilton AS, Lajkosz K, Cockburn JG, Bernardino RM, Al-Daqqaq Z, Penn LZ, Goldberg H, Saskin R, Fleshner NE.
PMID: 42378436 [PubMed - as supplied by publisher]


Intense Incidental F-18 DOPA Uptake in Low-grade Prostate Adenocarcinoma: A Potential Diagnostic Pitfall.
Clin Nucl Med
Mas Pascasio C, Ruíz de Almirón de Andrés B, López Rodríguez E, Sanz Viedma S.
PMID: 42377936 [PubMed - as supplied by publisher]


Efficacy, safety, and treatment feasibility of pembrolizumab plus lenvatinib in patients aged 75 years or older with advanced renal cell carcinoma: a Japanese multicenter retrospective study.
Int J Clin Oncol
Yamashita S, Yamasaki T, Ueda K, Tomida R, Toyoda S, Iwamoto H, Miyake M, Tomisaki I, Morizane S, Kohjimoto Y.
PMID: 42377813 [PubMed - as supplied by publisher]


Angiotensin Converting Enzyme (ACE) insertion/deletion (rs1799752) gene polymorphism and bladder cancer aggressiveness in Egyptian patients: A pilot case-control study.
Mol Biol Rep
Atia N, Osman Y, Abdel-Aziz AF, Refaat S, Khalil MR, Refaat M.
PMID: 42377753 [PubMed - indexed for MEDLINE]


4D flow MRI for the evaluation of venous anatomy and flow in renal cell carcinoma with venous tumor thrombus: a pictorial essay.
Abdom Radiol (NY)
Wentland AL, García-Rodríguez S, Roadman DF, Wieben O, Ansari N, Shapiro DD, Abel EJ.
PMID: 42377543 [PubMed - as supplied by publisher]


(18)F-Fluciclovine or (68)Ga-PSMA-11 PET/CT-guided Salvage Radiotherapy Changes in Postprostatectomy Biochemical Recurrence: Secondary Analysis of the EMPIRE-2 Trial.
Radiology
Abiodun-Ojo OA, Jani AB, Goyal S, Lawal IO, Halkar RK, Dhere V, Shelton JW, Patel PR, Schreibmann E, Hershatter B, Patel SA, Hanasoge S, Sebastian NT, Schuster DM.
PMID: 42377125 [PubMed - indexed for MEDLINE]


Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicine.
Expert Rev Anticancer Ther
Mercinelli C, Di Costanzo F, Oing C, Guandalini G, Maiorano BA, Sammarco E, Salfi A, Serafin D, Tateo V, Cigliola A, Piacentini M, Pastorino GL, Galli L, Conteduca V, Formisano L, Rescigno P, Necchi A.
PMID: 42376796 [PubMed - as supplied by publisher]


Common Bile Duct Diameter in Bladder Urothelial Carcinoma: A Case-Control Study.
Cancer Manag Res
Dadkhah A, Zolfaghari M, Bagheri SM, Soltani S, Fooladi Z, Emami M.
PMID: 42376600 [PubMed]


State of the nation: Understanding the current NHS treatment pathway to identify opportunities to advance future care of patients with high-risk non-muscle invasive bladder cancer in the UK (SPAN-UK).
BJUI Compass
Aning J, Catto JWF, Martin R, Chatterton K, Mariappan P, Ottley E, Hickey J, McCormack S, Gill S, Szabados B.
PMID: 42375995 [PubMed]


Prostate Cancer: Etiology, Diagnosis, and Treatment.
Serican J Med
Li C, Li Z, Liu X.
PMID: 42375929 [PubMed]


Holmium versus bipolar en bloc transurethral resection of urinary bladder tumors: a randomized controlled trial.
Cent European J Urol
Higazy A, Lotfy A, Tawfeek AM, Ali A, Radwan A.
PMID: 42375730 [PubMed]


Does body mass index affect the proper pre-operative grade and stage assessment in patients with prostate cancer undergoing radical prostatectomy?
Cent European J Urol
Drewa J, Adamowicz J, Juszczak K.
PMID: 42375717 [PubMed]


[Descriptive analytical study of patient survival with vertebral metastases in a rheumatological setting in Togo].
Pan Afr Med J
Oniankitan S, Diallo ML, Fianyo E, Ataké AE, Diallo MB, Komi TC, Koffi-Tessio VES, Kakpovi K, Houzou P, Oniankitan O.
PMID: 42375555 [PubMed - indexed for MEDLINE]


Case Report: Immune checkpoint inhibitor-associated myocarditis, myositis, and myasthenia gravis overlap syndrome with flow cytometric phenotyping before and after treatment in a patient with urothelial carcinoma.
Front Immunol
Gambina K, Tymm C, Paiola M, Tanji K, Zech J, Winchester R, Mor A, Gartshteyn Y.
PMID: 42375375 [PubMed - indexed for MEDLINE]


What should the urologist know on the management of kidney cancer in patients with Von Hippel-Lindau syndrome? Recommendations of the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group.
World J Urol
Erdem S, Amparore D, Re C, Verep S, Capitanio U, Larcher A, Roussel E, Klatte T, Bertolo R, Muselaers S, Pavan N, Kara O, Ingels A, Pecoraro A, Marchioni M, Pandolfo SD, Diana P, Carbonara U, Mollica V, Warren H, Borregales L, Marandino L, Sharma G, Caliň A, Wu Z, Lovati LA, Ciccarese C, Margue G, Francolini G, Flippot R, Leung DK, Mjaess G, Rosiello G, Mir MC, Palumbo C, Campi R, EAU-YAU Renal Cancer Working Group.
PMID: 42373875 [PubMed - indexed for MEDLINE]


Modified HoLEP technique: does it preserve ejaculation?
World J Urol
Spezzi Roncero LG, Montelli Yanzi G, Cristallo C, Tirapegui FI, Santillan D, Gonzalez MS.
PMID: 42373859 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 189297    Page 1 of 9465  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1